Home › Holistic care in Australia › TGA and Medical Cannabis
Education · TGA and medical cannabis
Reviewed by the Mediflora clinical team. This information is general in nature and is not medical advice.
Last reviewed 3 June 2026
The SAS Category B pathway is an application pathway available to prescribing healthcare practitioners including Medical Practitioners and Nurse Practitioners. When applying to access an unapproved medicinal cannabis product on behalf of a patient under the SAS Category B pathway, prescribers must provide a clinical justification. The justification should include the seriousness of the patient's condition, consideration for the use of medicines that are included in the ARTG and the potential risks and benefits of using the proposed unapproved medicine. The clinical justification may be succinct and should summarise:an outline of the patient's symptoms and/or diagnosisdetails of relevant past treatments and procedures trialled or considered, including reasons why therapeutic goods currently included in the ARTG may not be the most appropriate treatment for the individual patient in the particular circumstance an appraisal of the expected clinical benefits versus the potential risks of the proposed treatment. There are no restrictions on the medical conditions for which a prescriber may apply via the SAS to access an unapproved medicinal cannabis product for their patient, provided the prescriber has the appropriate knowledge on the condition being treated and on the medicinal cannabis product they wish to prescribe. Supporting evidence may be requested by the TGA for some novel indications.In some instances, evidence of specialist support from a practitioner with appropriate expertise may also be requested.
No GP referral is required to book with Mediflora. You'll need a phone, tablet or computer and a stable internet connection; you receive a secure link or call at your appointment time, with nothing to install. If you have a regular GP, your Mediflora doctor can — with your consent — share your care plan to keep them in the loop. General guidance on telehealth is available from healthdirect.
Yes. Mediflora operates a privacy-first model under the Australian Privacy Principles (APPs). Your consultation and records are confidential. In line with AHPRA advertising rules, we do not publish patient testimonials or before/after content.
Eligibility criteria apply to the discounted initial consultation; the offer may end without notice. Services are not Medicare-rebatable. Full pricing is on our pricing page.
No referral is required at Mediflora. You can book directly online, complete a short intake form, and have your first consultation — usually same-day or next-day.
A phone, tablet or computer with a stable internet connection. You'll receive a secure link or call at your appointment time — no special software to install.
Yes. Mediflora operates under the Australian Privacy Principles. Your consultation and records are confidential, and we do not publish testimonials or before/after content.
Ready to talk to an AHPRA-registered doctor?
Same-day & next-day appointments · no referral needed · telehealth Australia-wide.
General health information, not medical advice; it does not replace a consultation with a qualified clinician. Verify independently: healthdirect, AHPRA.